Skip to main content

Advertisement

SpringerLink
Log in

Thyroid cancer is the most common cancer associated with acromegaly

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

The aim of the study was to screen the malignancy in an acromegalic patient group and to determine whether there was any increased risk and the incidence of malignancy and its association with disease characteristics such as duration of disease, latency in diagnosis, and GH and IGF-1 levels. One hundred-five (65 female, 40 male) patients with acromegaly followed and treated at Cerrahpasa Medical School, Endocrinology and Metabolism outpatient clinic between 1983 and 2007 were included in this study. The patients were screened with colonoscopy, mammography, and thyroid and prostate ultrasonography (US). Malignancy was detected in 16 (15%) patients. Thyroid cancer was found in 5 patients (4.7%), breast cancer in 3 (2.8%), colon cancer in 2 (1.9%), lung cancer in 2 (1.9%), cervix cancer in 1 (0.9%), myelodysplastic syndrome (MDS) in 1 (0.9%), cholangiocarcinoma in 1 (0.9%), and multiple endocrine neoplasm (MEN) type 1 in 1 patient (0.9%). Cancer was more common in the male patients (P = 0.046) and high levels of GH increased the risk of cancer development (P = 0.046). In this series, the most commonly detected cancer types were thyroid followed by breast and colon cancers. Although high levels of initial GH seemed to increase the risk of cancer development in acromegalic patients, age, gender, age at the time of diagnosis, duration of disease, and initial IGF-I levels were not associated with cancer development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Melmed S (2006) Acromegaly. N Engl J Med 355:2558–2573

    Article  CAS  PubMed  Google Scholar 

  2. Ayuk J, Sheppard MC (2008) Does acromegaly enhance mortality? Rev Endocr Metab Disord 9:33–39

    Article  PubMed  Google Scholar 

  3. Melmed SM (2001) Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 86:2929–2934

    Article  CAS  PubMed  Google Scholar 

  4. Cohen P, Clemmons DR, Rosenfeld RG (2000) Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 10:297–305

    Article  CAS  PubMed  Google Scholar 

  5. Renehan AG (2008) Acromegaly, growth hormone and cancer risk. Best Pract Res Clin Endocrinol Metab 22(4):639–657

    Article  CAS  PubMed  Google Scholar 

  6. Webb Susan M, Felipe C, Wass John AH (2002) Oncological complications of excess GH in acromegaly. Pituitary 5:21–25

    Article  CAS  PubMed  Google Scholar 

  7. Jenkins P, Mukherjeet A, Shalet SM (2006) Does growth hormone cause cancer? Clin Endocrinol 64:121

    Article  Google Scholar 

  8. Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83:2730–2734

    Article  CAS  PubMed  Google Scholar 

  9. Jenkins PJ (2006) Cancers associated with acromegaly. Neuroendocrinology 83:218–223

    Article  CAS  PubMed  Google Scholar 

  10. Loeper S, Ezzat S (2008) Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord 9:41–58

    Article  CAS  PubMed  Google Scholar 

  11. Nabarro JD (1987) Acromegaly. Clin Endocrinol 26:481–512

    Article  CAS  Google Scholar 

  12. Barzilay J, Heatley GJ, Cushing GW (1991) Benign and malignant tumors in patients with acromegaly. Arch Intern Med 151:1629–1632

    Article  CAS  PubMed  Google Scholar 

  13. Melmed S (1996) Unwanted effects of GH excess in the adult. J Pediatr Endocrinol Metab 9:369–374

    PubMed  Google Scholar 

  14. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF (1991) Acromegaly and gastrointestinal cancer. Cancer 68:1673–1677

    Article  CAS  PubMed  Google Scholar 

  15. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z, Marinkovic J (1998) Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin Endocrinol (Oxf) 49:441–445

    Article  CAS  Google Scholar 

  16. Giustina A, Barkan A, Casanueva F, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526–529

    Article  CAS  PubMed  Google Scholar 

  17. Tiryakioglu O, Kadioglu P, Caneroglu NU, Hatemi H (2003) Age dependency of serum insulin-like growth factor (IGF-1) in healthy Turkish adolescents and adults. Indian J Med Sci 57:543–548

    CAS  PubMed  Google Scholar 

  18. Mustacchi P, Shimkin MB (1957) Occurrence of cancer in acromegaly and in hypopituitarism. Cancer 10(1):100–104

    Article  CAS  PubMed  Google Scholar 

  19. Klein L, Parveen G, Gavaler JS, Vanthiel DH (1982) Colonic polpys in patients with acromegaly. Ann Intern Med 97(1):27–30

    CAS  PubMed  Google Scholar 

  20. Brunner JE, Johnson CC, Zafar S, Peterson EL, Brunner JF, Mellinger RC (1990) Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol 32:65–71

    Article  CAS  Google Scholar 

  21. Higuchi Y, Saeki N, Iuchi T, Uchino Y, Tatsuno I, Uchida D et al (2000) Incidence of malignant tumors in patients with acromegaly. Endocr J 47(supply):57–60

    Article  Google Scholar 

  22. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni JF Jr (2002) Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13:395–400

    Article  CAS  PubMed  Google Scholar 

  23. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–150

    Article  CAS  PubMed  Google Scholar 

  24. Tornell J, Rymo L, Isaksoon OG (1991) Induction of mammary adenocarcinomas in metallothionein promoter- human growth hormone transgenic mice. Int J Cancer 49:114–117

    Article  CAS  PubMed  Google Scholar 

  25. Kaulsay KK, Zhu T, Bennett W, Lee K, PE LobieE (2001) The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behaviour are mediated via the hGH receptor. Endocrinology 142:767–777

    Article  CAS  PubMed  Google Scholar 

  26. Zhu T, Goh EL, Graichen R, Ling L, Lobie PE (2001) Signal transduction via the growth hormone receptor. Cell Signal 13(9):599–616

    Article  CAS  PubMed  Google Scholar 

  27. Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119:3189–3202

    Article  CAS  PubMed  Google Scholar 

  28. Baserga R (2000) The contradictions of the insulin-like growth factor 1 receptor. Oncogene 19:5574–5581

    Article  CAS  PubMed  Google Scholar 

  29. Fidaner C, Eser SY, Parkin DM (2001) Incidence in Izmir in 1993–1994: first results from Izmir cancer registry. Eur J Cancer 37:83–92

    Article  CAS  PubMed  Google Scholar 

  30. Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, Uberti EC, Pezzino V (2005) High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol 63:161–167

    Article  Google Scholar 

  31. Balkany C, Cushing GW (1995) An association between acromegaly and thyroid carcinoma. Thyroid 5:47–50

    Article  CAS  PubMed  Google Scholar 

  32. Franceschi S, Preston Martin S, DalMaso L, Negri E, LaVecchia C, Mack WJ, McTiernan A, Kolonel L, Mark SD, Mabuchi K, Jin F, Wingren G, Galanti R, Hallquist A, Glattre E, Lund E, Levi F, Linos D, Ron E (1999) A pooled analysis of case control studies of thyroid cancer. Benign thyroid diseases. Cancer Causes Control 10:583–595

    Article  CAS  PubMed  Google Scholar 

  33. From G, Mellemgaard A, Knudsen N, Jorgensen T, Perrild H (2000) Review of thyroid cancer cases among patients with previous benign thyroid disorders. Thyroid 10:697–700

    Article  CAS  PubMed  Google Scholar 

  34. Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, Camanni F, Liuzzi A (2002) Acromegaly Study Group of the Italian Society of Endocrinology. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 25:240–245

    CAS  PubMed  Google Scholar 

  35. Kurimoto M, Fukuda I, Hizuka N, Tkano K (2008) The prevalance of benign and malign tumors in patients with Acromegaly at a single institute. Endocr J 55:67–71

    Article  PubMed  Google Scholar 

  36. Li BD, Khosravi MJ, Berkel HJ, Diamandi A, Dayton MA, Smith M, Yu H (2001) Free insulin-like growth factor-I and breast cancer risk. Int J Cancer 91:736–739

    Article  CAS  PubMed  Google Scholar 

  37. Laban C, Bustin SA, Jenkins PJ (2003) The GH-IGF-I axis and breast cancer. Trends Endocrinol Metab 14:28–34

    Article  CAS  PubMed  Google Scholar 

  38. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393–1396

    Article  CAS  PubMed  Google Scholar 

  39. Renehan AG, Bhaskar P, Painter JE, O’Dwyer ST, Haboubi N, Varma J, Ball SG, Shalet SM (2000) The prevalence and characteristics of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3417–3424

    Article  CAS  PubMed  Google Scholar 

  40. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA, Besser M (1997) Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf) 47:17–22

    Article  CAS  Google Scholar 

  41. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO (1997) Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 76:1115–1118

    CAS  PubMed  Google Scholar 

  42. Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D (1998) Insulin-like growth factor 1 and prostate cancer risk: a population based, case control study. J Natl Cancer Inst 90:911–915

    Article  CAS  PubMed  Google Scholar 

  43. Harman SM, Metter EJ, Blackman MR, Landis PK, Carter HB (2000) Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 85:4258–4265

    Article  CAS  PubMed  Google Scholar 

  44. Chan JM, Stampfer MJ, Giovanucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 279:563–566

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Cerrahpasa Tip Fakültesi, Cerrahpasa Medical School, University of Istanbul, Ic Hastalıkları Anabilim Dali, Endokrinoloji-Metabolizma ve Diyabet Bilim Dali, Cerrahpasa, 34303, Istanbul, Turkey

    Bennur Esen Gullu, Ozlem Celik & Pinar Kadioglu

  2. Department of Neurosurgery, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey

    Nurperi Gazioglu

Authors
  1. Bennur Esen Gullu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ozlem Celik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nurperi Gazioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pinar Kadioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pinar Kadioglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gullu, B.E., Celik, O., Gazioglu, N. et al. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 13, 242–248 (2010). https://doi.org/10.1007/s11102-010-0224-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-010-0224-9

Keywords

Search

Navigation